Theratechnologies EV/EBIT
Qual é o EV/EBIT de Theratechnologies?
O EV/EBIT de Theratechnologies Inc. é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Theratechnologies
O que Theratechnologies faz?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas com ev/ebit semelhantes a Theratechnologies
- DATATRAK International tem EV/EBIT de N/A
- New York Mortgage Trust Inc tem EV/EBIT de N/A
- Surface Oncology Inc tem EV/EBIT de N/A
- Deciphera Pharmaceuticals Inc tem EV/EBIT de N/A
- Nymox Pharmaceutical Corp tem EV/EBIT de N/A
- Walker River Resources tem EV/EBIT de N/A
- Theratechnologies tem EV/EBIT de N/A
- Palred Technologies tem EV/EBIT de N/A
- Eton Pharmaceuticals tem EV/EBIT de N/A
- The Very Good Food tem EV/EBIT de N/A
- Jangada Mines Plc tem EV/EBIT de N/A
- Northern Lion Gold tem EV/EBIT de N/A
- Just Plc tem EV/EBIT de N/A